Fingerprint
Dive into the research topics of 'It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann*
*Corresponding author for this work